Menopause after a hysterectomy when your ovaries were left in

Short answer

The symptoms of menopause after a hysterectomy with ovaries intact are the ordinary ones — hot flashes, night sweats, broken sleep, vaginal dryness, mood changes, joint aches — with one difference that changes how you notice them: no periods. Your ovaries were left in place and keep making hormones, so removing the uterus is not menopause. But in prospective studies, women who had a hysterectomy with their ovaries conserved reached ovarian failure earlier than women of the same age who did not (1).

If you were told "we're keeping your ovaries, so you won't go through menopause" and then started waking up soaked at 43, you are not imagining it and you are not being dramatic. Two separate things were true in that sentence and only one of them got said out loud. Your ovaries do keep working — and the research still finds, on average, an earlier end to that work. What follows is clear about what is known, what is only an association, and what nobody has settled.

Note: this article is educational and is not medical advice. It cannot tell you whether you are in menopause, and no app or wearable can. New, changing or worsening symptoms after surgery need a clinician, and some need one today — the red flags are marked throughout, not only at the end.

Does a hysterectomy cause menopause?

No. Menopause is what happens when the ovaries stop releasing eggs and making the hormones that go with it. The uterus does not make estrogen. Remove it, leave both ovaries in place, and those ovaries carry on working — which is why ovarian conservation is standard for younger women having surgery for non-cancerous reasons. The Menopause Society's 2022 hormone therapy position statement puts it as a recommendation: "Ovarian conservation is recommended when hysterectomy is performed for benign indications in premenopausal women at average risk for ovarian cancer" (5).

The short version your surgeon gave you was true. The part usually left out has two halves.

First: in observational research, hysterectomy with ovarian conservation is associated with earlier ovarian failure. The size of "earlier" depends on which study you read.

Second, and the half that shapes daily life: the marker you would normally use is gone. Most women work out that they are in perimenopause because their cycle changes, and so does the research. The Stages of Reproductive Aging Workshop + 10, the consensus system used to stage reproductive ageing, is anchored on bleeding criteria, which the 2011 update simplified for the early and late menopausal transition (9). After a hysterectomy there is no bleeding to read. The clock is still running; the face has been taken off it.

That is the real subject here: not "will I go through menopause early" — nobody can tell you that — but "how do I know what is happening when the usual sign is missing."

What are the symptoms of menopause after hysterectomy with ovaries intact?

They are the ordinary ones, because the process is the ordinary one. The UK's NICE guideline lists, alongside changes in the menstrual cycle, vasomotor symptoms (hot flushes and sweats), genitourinary symptoms such as vaginal dryness, effects on mood including depressive symptoms, musculoskeletal symptoms such as joint and muscle pain, and sexual difficulties such as low desire, adding that symptoms "may vary from minor to severe and be experienced over short or long time periods" (4).

What is different is the list of things you can mistake them for. After major surgery, "tired, aching, sleeping badly, not feeling like yourself" also describes recovery, anaemia, thyroid problems and low mood, and there is no cycle underneath to tell you which you are looking at. That is why it is worth writing things down.

The timeline surprises people. In the Study of Women's Health Across the Nation, which followed 3,302 women at seven US sites, frequent vasomotor symptoms lasted a median of 7.4 years in total and persisted a median of 4.5 years after the final menstrual period; women who were premenopausal or early perimenopausal when symptoms began had the longest run, a median of more than 11.8 years, and Black women the longest total duration, a median of 10.1 years (7). Whatever starts is unlikely to be over in a season.

And here is the part that does not belong in a tracking diary. Night sweats that nothing else explains, that go on for months with unexplained weight loss, fever, a lump you can feel, or breathlessness, are a different conversation. NICE's suspected cancer guideline lists night sweats alongside unexplained lymphadenopathy or splenomegaly as a reason to consider a suspected cancer pathway referral, and names fever, shortness of breath, itching and weight loss as associated symptoms to take into account (13). That is not a reason to fear your own sweating. It is a reason not to log a symptom for six months instead of showing someone.

How will I know I'm in menopause without periods?

By symptoms, mostly — and that is not a workaround, it is what the guideline says to do.

NICE instructs clinicians to diagnose menopause "in those who have had a hysterectomy, based on the type and combination of symptoms they have (for example, vasomotor symptoms)" (4). For everyone else aged 45 or over it uses either twelve months without a period, or recently started vasomotor symptoms plus menstrual change. You get the symptom route by default, because the other two are not available.

That makes the quality of your description the main instrument. "I've been having hot flashes for a while" and "since March I've had four to seven flushes most days and I wake soaked twice a week" are not the same consultation.

What about a blood test? Here expectations and guidance part company. NICE says not to use anti-Müllerian hormone, inhibin A, inhibin B, oestradiol, antral follicle count or ovarian volume to identify perimenopause or menopause in people aged 45 or over, and to consider a follicle-stimulating hormone (FSH) test only in people aged 40 to 45 with menopause-associated symptoms, or under 40 where menopause is suspected. For premature ovarian insufficiency under 40 it asks for elevated levels on two samples four to six weeks apart, and says plainly: do not diagnose on a single blood test (4). Levels in the transition swing, and a single FSH value is a photograph of a moving object. The large studies here used FSH of 40 IU/L or higher as their working definition of ovarian failure because they needed one fixed rule to compare groups (1, 3) — a research convention, not a verdict on an individual.

So the practical answer is a record. Dates, symptoms, how often, how bad, what it cost you, kept for weeks rather than days — one bad fortnight tells you very little, three months of the same thing tells you a great deal. Our guide to menopause covers the wider picture.

Alongside that record, keep one short list of things that are not for the diary. A fever. Pain, swelling, warmth or redness in one calf. Sudden breathlessness or chest pain. New vaginal bleeding. Discharge from or opening of the surgical wound. Those go to your surgeon or to emergency care the same day, not into a tracking app — whether surgery was three weeks ago or three years ago.

What does the research actually show?

Three prospective studies carry most of the weight, and each has a limit worth knowing.

Two things are worth pulling out of that table.

The most important sentence in this literature is a disclaimer. Moorman and colleagues, having found the association, wrote: "it is unresolved whether it is the surgery itself or the underlying condition leading to hysterectomy that is the cause of earlier ovarian failure" (1). Women do not have hysterectomies at random: fibroids, endometriosis, adenomyosis and heavy bleeding are reasons for surgery, and may travel with something that also affects the ovaries. Any sentence telling you a hysterectomy caused your early menopause goes further than the evidence does.

The "how much earlier" number depends on where you measure. Moorman's group put the gap between the points at which 15% of each group reached ovarian failure at 1.88 years (95% CI 1.39–2.37) (1); the Trabuco paper, reporting on the same cohort study, describes the hysterectomy group becoming menopausal 1.9 years earlier than referents (2). Farquhar's 3.7-year figure sits inside a subgroup. The fair summary is "on average, around a year or two earlier, with wide uncertainty," not "four years."

The long-term row argues for ordinary preventive care rather than alarm — knowing your blood pressure and lipids, and discussing bone health. Moorman's team drew the same conclusion: "because not all women will experience overt symptoms of menopause, women who have undergone premenopausal hysterectomy may warrant closer monitoring of bone density or cardiovascular risk factors" (1). The usual alarm has been disconnected, and some of what follows is silent. On how far your own numbers can sit from a group average, see our piece on what a normal resting heart rate means.

Why would surgery affect ovaries that were left in place?

Nobody is certain, and the people who found the association say so. The leading idea is blood supply: that removing the uterus reduces ovarian blood flow and with it hormone production. Moorman's team summarised the evidence in one sentence: "The evidence for this mechanism is mixed, with most but not all studies finding a reduction in ovarian blood flow after hysterectomy" (1). A second hypothesis they describe is endocrine rather than vascular: that the uterus exerts some inhibitory influence on pituitary FSH secretion, so removing it allows FSH to rise and speeds the loss of follicles (1). A third possibility is not a mechanism at all but the selection problem above: if the condition that led to surgery was already affecting ovarian ageing, the surgery would be a marker rather than a cause.

Trabuco's AMH findings are the closest thing to a direct physiological signal: from a similar starting point, the hysterectomy group's ovarian reserve marker fell further over one year, which the authors say suggests hysterectomy "may lead to ovarian damage that is unrelated to baseline ovarian reserve" (2). Note the may, and the limitation in the same abstract: the absolute change was not significantly different between groups. In practice this means something modest — reason to pay attention sooner than you otherwise would, and no reason to assume anything has already happened.

What if my ovaries were removed too?

Then the situation differs in kind, and most of this article does not apply to you. Removing both ovaries ends ovarian hormone production at the moment of surgery rather than over years. The Menopause Society describes it directly: "The surgical removal of both ovaries leads to a much more abrupt loss of the ovarian steroids estrogen and progesterone than does natural menopause and includes a significant decrease in testosterone that does not occur with natural menopause," and notes that vasomotor and other estrogen-deficiency symptoms "are more frequent and more severe after oophorectomy" (5). We cover that situation in hot flashes and night sweats after a hysterectomy, which goes through surgical menopause in detail. The hormone therapy section below applies to both, with the caveat that guidance for women who lost both ovaries early is more emphatic.

If only one ovary was removed, you sit between the two. Both Moorman and Farquhar found larger effects in that group — HR 2.93 (95% CI 1.57–5.49) for ovarian failure (1), and menopause 4.4 years earlier (95% CI 0.6–7.9) than women in the hysterectomy group who kept both (3). Mention it explicitly at appointments; it is the kind of detail that falls out of a referral letter.

Is hormone therapy an option?

It is an option professional bodies name; the decision belongs to you and your doctor. This section reports what the guidelines say rather than giving advice.

What the guidelines say, with the conditions they attach. The Menopause Society's 2022 position statement opens with the line "Hormone therapy remains the most effective treatment for vasomotor symptoms (VMS) and the genitourinary syndrome of menopause and has been shown to prevent bone loss and fracture", and for women whose ovarian function ends early it states that "In the absence of contraindications, hormone therapy is recommended at least until the average age of menopause (approximately age 52 y), with an option for use of oral contraceptives in healthy younger women" (Level II) — while listing, in the same document, the contraindications it has in mind: "unexplained vaginal bleeding; liver disease; prior estrogen-sensitive cancer (including breast cancer); prior coronary heart disease (CHD), stroke, MI, or VTE; or personal history or inherited high risk of thromboembolic disease" (5). ACOG's Committee Opinion 698 on hormone therapy in primary ovarian insufficiency sets the endpoint at a different age — "Treatment for all women with primary ovarian insufficiency should continue until the average age of natural menopause is reached (age 50–51 years)" — and conditions it the same way, on there being "no contraindications to treatment" (6). NICE takes the same shape without naming a number, telling clinicians to offer hormone replacement therapy or a combined hormonal contraceptive to people with premature ovarian insufficiency "unless contraindicated (for example, in people with hormone-sensitive cancer)" and to continue "until at least the age of natural menopause"; where there are contraindications, it asks clinicians to give advice on bone and cardiovascular health and on symptom management instead (4). Two bodies, two numbers — roughly 52 and 50 to 51 — which is itself the point: nobody should give you a single figure, and no guideline applies until a clinician has checked that contraindication list against your own history.

Two points are often misquoted. First, The Menopause Society states as a Level II recommendation that "Results of the WHI trials in older women do not apply to women with POI or premature or early menopause" (5). Second, saying nothing is not neutral: the same statement finds that "The strongest evidence from meta-analyses and systematic reviews links early loss of ovarian function to decreased quality of life and increased risk of fracture, CVD, heart failure, diabetes mellitus (DM), and overall mortality" (5), and ACOG lists the sequelae of primary ovarian insufficiency as vasomotor symptoms, urogenital atrophy, osteoporosis and fracture, cardiovascular disease and increased all-cause mortality (6). Whatever you decide, it should be a decision rather than a drift.

If hormone therapy is not for you. The Menopause Society's 2023 statement on non-hormone management of vasomotor symptoms recommends cognitive-behavioural therapy, clinical hypnosis, selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors, gabapentin and fezolinetant at Level I evidence, oxybutynin at Levels I–II, and weight loss and stellate ganglion block at Levels II–III. It does not recommend paced respiration, supplements and herbal remedies, cooling techniques, trigger avoidance, exercise, yoga, mindfulness-based intervention, relaxation, soy foods and extracts, cannabinoids or acupuncture for this purpose (10). Prescription options are a conversation with a prescriber; no doses appear here. One structural detail: NICE advises oestrogen-only hormone replacement therapy for people who have had a total hysterectomy, and combined therapy for people who still have a uterus (4) — the progestogen exists to protect the endometrium, which you no longer have.

What can you track when there is no cycle to watch?

Four things, none of which needs a device.

1. Vasomotor events, with a count and a time. Not "lots" — a number, and day or night. Patterns over weeks are what a clinician can use; one bad week is noise.

2. Nights. How many times you woke, whether you had to change anything, how you felt next day. In the STRIDE cohort of 623 women aged 40 to 65, 370 (59%) reported hot flashes, and it was hot flashes with bother — not hot flashes alone — that were associated with sleep disturbance (11). What a symptom costs you is a separate measurement from how often it happens, and the one that goes unrecorded.

3. The symptoms that do not announce themselves. Joint and muscle aches, low mood, vaginal dryness, concentration — NICE lists these as menopause-associated, and they are the ones filed under "getting older" or "still recovering" (4).

4. Your own physiological baseline, as context rather than evidence. Night-time and resting heart rate, sleep length and heart rate variability, recorded the same way every day, give you a personal record to set beside your notes. They are not a test for menopause and cannot be read as one. The ceiling is low: in a study that monitored 41 peri- and postmenopausal women with nightly sternal skin conductance — the laboratory method for detecting hot flashes objectively — participants had a median of two physiologically monitored and one reported hot flash per night, and sleep complaints were not significantly related to the frequency of the monitored ones (12). Research-grade equipment and a woman's own account disagree; your account goes in the record, and the numbers are margin notes.

None of that applies to the following, which need a clinician rather than a log. A temperature. Pain, swelling, warmth or redness in one calf: the CDC lists swelling, pain or tenderness, warmth and redness or discoloration as the signs of deep vein thrombosis, notes that about half of people with a clot have no symptoms, and says to see a doctor as soon as possible (14). Difficulty breathing, chest pain worse on breathing in or coughing, a fast or irregular heartbeat, coughing up blood, or feeling faint are the symptoms of pulmonary embolism, and the CDC says to seek medical help immediately (14) — in the US, call 911. New vaginal bleeding, wound discharge or a wound that opens goes to your surgical team, not into a notebook.

Living with menopause after a hysterectomy: the questions people ask next

Can I keep working through this if nobody can see anything is wrong?

Most people do, and the difficulty is invisibility rather than capacity. Without periods there is no outward marker, which makes small adjustments harder to ask for. What helps is specificity: a count of disrupted nights over a month, which parts of the day are worst, and one or two concrete requests — control over room temperature, a desk away from a heat source, a later start after a bad night. NICE recognises that menopause symptoms range from minor to severe and can last over long periods (4), which is useful language when you need an official source.

Should I still exercise, and does it help the hot flashes?

Exercise is worth doing for general health, bone and cardiovascular reasons, but on flashes specifically the evidence is thin: The Menopause Society's 2023 non-hormone position statement does not recommend exercise, yoga, relaxation or mindfulness-based intervention as treatments for vasomotor symptoms, placing them at Level II evidence (10). That is a narrow judgement about one symptom, not a verdict on exercise. When you return to activity after your own surgery, and how much, is a question for the surgeon who did it.

What about travel, weddings and anything with a dress code?

The practical problems are heat, layers and not controlling your own thermostat. Things people plan around: fabrics that dry fast, a spare top, aisle seats, knowing where the cool air is in an unfamiliar venue — and hotel rooms are often warmer than home. One caution: The Menopause Society's 2023 statement lists cooling techniques and trigger avoidance among approaches it does not recommend as treatments, on Level II evidence (10). They can make an evening more comfortable; they are not therapy.

Do food and alcohol make it worse?

The evidence is thinner than the internet suggests. The Menopause Society's 2023 review does not recommend dietary modification, soy foods, soy extracts, equol, or supplements and herbal remedies for vasomotor symptoms, placing dietary modification at Level III — consensus and expert opinion only (10). Weight loss is the one lifestyle item it does recommend, at Levels II–III. A reasonable approach is to test your own case: note what you drank or ate on the evenings before your worst nights. That is a personal association, not proof.

Why is my sleep so bad when the flashes aren't that frequent?

Because frequency and cost are different measurements. In the STRIDE cohort, reporting hot flashes with bother was associated with sleep disturbance, while reporting hot flashes alone was not (11). Two flashes that wake you fully and leave you changing a shirt at 3am cost more than six mild ones in the afternoon. Anxiety about sleep compounds it, and watching sleep data closely can make it worse — our piece on orthosomnia covers that trap.

I feel unlike myself and people keep saying it's stress. How do I tell?

You may not be able to tell from the inside, and that is not a failure of self-knowledge. Mood changes are on NICE's list of menopause-associated symptoms, alongside joint pain and sexual difficulties (4), and they overlap almost completely with the symptoms of a hard year. What separates them is pattern over time. A record covering several months, with mood noted next to nights, flashes and aches, gives a clinician something a single tearful appointment cannot. Persistent or severe low mood is its own reason to seek help.

How do I explain this to my family when I don't have periods to point at?

Pick the concrete over the hormonal. "I was awake from two until four and changed my top twice" lands better than "my estrogen is doing something." If someone wants an external source, the duration figures help: in SWAN, frequent vasomotor symptoms lasted a median of 7.4 years and persisted a median of 4.5 years beyond the final period (7). Say the structural thing out loud once too: because the uterus is gone there is no visible sign, so nobody — including you — gets a warning.

Is this permanent, or does it settle?

Vasomotor symptoms are not permanent for most women, though "temporary" here means years rather than months: SWAN's median total duration was 7.4 years, with wide variation by when symptoms started and by race (7). Some changes — genitourinary symptoms in particular — tend not to resolve on their own, and ovarian function does not come back once it has ended. What you have most influence over is whether anyone is paying attention early (5).

How to bring this up with your doctor

Appointments are short, and this topic is easy to lose inside "recovering from surgery."

Say it in one sentence first: "I had a hysterectomy with my ovaries left in, I have no periods to go by, and since [month] I've had symptoms that look like menopause — here is what I recorded."

Bring a one-page summary, not the whole diary. A count of vasomotor events by week, disrupted nights, the other symptoms with rough start dates, and anything that changed when something else did. Label any physiological data as your own trends, not as findings.

Bring your operative details. Which organs were removed, whether one ovary went too, the date, and the reason for surgery. Whether you had a unilateral oophorectomy matters: it is associated with larger effects in both prospective studies here (1, 3).

Ask what the diagnostic route is for someone without periods. NICE's answer is the type and combination of symptoms; it reserves FSH for people aged 40 to 45 with symptoms and for people under 40, asking for two samples four to six weeks apart before diagnosing premature ovarian insufficiency (4).

Ask about the long view, not just the symptoms. Bone and cardiovascular health are why the guidelines care about early estrogen loss (5, 6), and Moorman's team suggested closer monitoring of bone density or cardiovascular risk factors for this group (1).

And do not file these under menopause. A fever. Pain, swelling, warmth or redness in one calf. Sudden breathlessness, chest pain worse on breathing in, a fast or irregular heartbeat, coughing up blood, or feeling faint — the CDC's instruction for suspected pulmonary embolism is to seek medical help immediately (14); call 911 in an emergency. New vaginal bleeding, wound discharge or a wound that opens goes to your surgical team. Night sweats that persist for months with unexplained weight loss, a lump you can feel or fever need investigating rather than tracking (13).

How Welltory helps — and what it cannot do

The limits first. Welltory is a general wellness product, not a medical device. It does not diagnose, predict, monitor, prevent, treat or mitigate menopause, ovarian insufficiency or any other condition, and it cannot tell you whether your ovaries have stopped working. It has no symptom tracker and no cycle tracking. The formula is narrower than people expect: you mark what happened, the app keeps the measurements, and together they make a diary. The app is not the witness. You are.

1. Mark the night yourself. If you wear an Apple Watch or Oura, the Today screen on iOS flags stress stretches and asks "What happened?". Tap a suggested tag, type a few words, or just talk: "woke up soaked", "hot flash", "changed the sheets", "awake 2–4", "fog", "aching", "flat today". You can add a note any time with the plus icon; it goes into your Journal.

Some nights are not diary material. A temperature, a painful or swollen calf, sudden breathlessness or chest pain, new bleeding or a wound that opens are a call to your surgical team or emergency care the same day, not a tag (14).

2. Look at the day or two around a marked night. Put resting heart rate, sleep analysis, stress minutes, Battery and your HRV readings beside the nights you tagged. These are your own trends against your own history — not a population range, not a normal-versus-abnormal reading. If the numbers look unremarkable on a night you remember as awful, believe yourself (why that happens).

3. Take the morning reading the same way each day. A phone-camera (PPG) measurement needs a fingertip over the camera and flash, held still. It is one snapshot, not continuous monitoring and not an ECG; a compatible chest strap, Apple Watch or Samsung Watch can be read instead. Heartbeat Report is built for same-conditions morning readings — see how accurate phone-camera HRV is.

4. Check My Patterns after two to three weeks of tagging. My Patterns collects the tags you add to stress and rest stretches, so it needs iOS with an Apple Watch or Oura. Patterns start at around 7 tagged events; insights typically need 7 occurrences of a tag this month plus history from last month. It shows which tagged situations coincide with stressful stretches, day-of-week trends, heart rate during those episodes, and every time a tag occurred. Some sections need a paid plan.

5. Build a record for the appointment. The Journal holds your HRV measurements, tags, mood, notes and workouts; for a longer record, export a CSV from the web app (Dashboard → choose a chart → Export) and bring it with your own count of flashes and disrupted nights. The free version keeps 30 days.

Any pattern you find is an association to discuss with your doctor — not proof of a cause, and not a warning system.

Where to find other people in the same situation. If you are living with a condition that limits your energy, Welltory runs a paid, moderated community called Energy Lab for women aged 18 to 65 living with energy-limiting conditions — ME/CFS, long COVID, fibromyalgia, POTS, MCAS and similar. You keep collecting your own data, and the Lab is where people learn to read it together, with a medical board answering the science. It is education and peer support, not medical care, with a 14-day money-back guarantee on a first purchase.

How we made it

Made with AI tools, then edited and fact-checked by the Welltory team. See our Editorial & AI policy.

Data analysis by Jane Smorodnikova, co-founder of Welltory and the person who built the methodology behind how we read physiological data.

Written by Tatsiana Yashyna.

Discounts for blog readers: up to 36% off

See what affects your energy, stress, sleep, and daily state with Welltory

Explore your data